N

NLS Pharmaceutics Ltd
D

NLSP

1.94000
USD
-0.12
(-5.83%)
مغلق
حجم التداول
5,665
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
7,869,847
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Nls Pharmaceutics Ltd

القطاع: Healthcare
الصناعة: Biotechnology
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.